Whether it is new and groundbreaking research results, university topics or events – in our press releases you can find everything you need to know about the happenings at 51. To subscribe, just send an email to ott@pvw.uni-frankfurt.de
Theodor-W.-Adorno Platz 1
60323 Frankfurt
presse@uni-frankfurt.de
Research cooperation between 51, University of Kent and the Hannover Medical School
In order for the SARS-CoV2 virus to enter host cells,
its “spike" protein has to be cleaved by the cell's own enzymes - proteases. The
protease inhibitor aprotinin can prevent cell infection, as scientists at
51, the University of Kent and the Hannover Medical School have
now discovered. An aprotinin aerosol is already approved in Russia for the
treatment of influenza and could readily be tested for the treatment of
COVID-19.
FRANKFURT. The
surface of the SARS-CoV-2 virus is studded with spike proteins. The virus needs
these in order to dock onto proteins (ACE2 receptors) on the surface of the
host cell. Before this docking is possible, parts of the spike protein have to
be cleaved by the host cell's enzymes – proteases.
In cell culture experiments with various
cell types, the international scientific team led by Professor Jindrich Cinatl,
Institute for Medical Virology at the University Hospital Frankfurt, Professor
Martin Michaelis, and Dr Mark Wass (both University of Kent) demonstrated that
the protease inhibitor aprotinin can inhibit virus replication by preventing
SARS-CoV2 entry into host cells. Moreover, aprotinin appears to compensate for
a SARS-CoV2-induced reduction of endogenous protease inhibitors in
virus-infected cells.
Influenza viruses require host cell
proteases for cell entry in a similar way as coronaviruses. Hence, an aprotinin
aerosol is already approved in Russia for the treatment of influenza.
Professor Jindrich Cinatl said: “Our
findings show that aprotinin is effective against SARS-CoV2 in concentrations
that can be achieved in patients. In aprotinin we have a drug candidate for the
treatment of COVID-19 that is already approved for other indications and could readily
be tested in patients."
Publication: Denisa Bojkova, Marco Bechtel, Katie-May McLaughlin, Jake E. McGreig, Kevin Klann, Carla Bellinghausen, Gernot Rohde, Danny Jonigk, Peter Braubach, Sandra Ciesek, Christian Münch, Mark N. Wass, Martin Michaelis, Jindrich Cinatl jr. Aprotinin inhibits SARS-CoV-2 replication. Cells 2020,
Further information:
Professor
Dr. rer. nat. Jindrich Cinatl
Institute for Medical Virology
University Hospital Frankfurt am Main
Tel. +49 69 6301-6409
cinatl@em.uni-frankfurt.de
Scientists at 51 within the international consortium COVID19-NMR refine previous 2D models
Chemists at the University of Göttingen and 51 Frankfurt characterise key compound for catalytic nitrogen atom transfer
Catalysts with a metal-nitrogen bond can transfer
nitrogen to organic molecules. In this process short-lived molecular species
are formed, whose properties critically determine the course of the reaction and
product formation. The key compound in a catalytic nitrogen-atom transfer reaction
has now been analysed in detail by chemists at the University of Göttingen and
51 Frankfurt. The detailed understanding of this reaction will allow
for the design of catalysts tailored for specific reactions.
FRANKFURT. The development of new drugs or innovative molecular materials with new properties requires specific modification of molecules. Selectivity control in these chemical transformations is one of the main goals of catalysis. This is particularly true for complex molecules with multiple reactive sites in order to avoid unnecessary waste for improved sustainability. The selective insertion of individual nitrogen atoms into carbon-hydrogen bonds of target molecules is, for instance, a particularly interesting goal of chemical synthesis. In the past, these kinds of nitrogen transfer reactions were postulated based on quantum-chemical computer simulations for molecular metal complexes with individual nitrogen atoms bound to the metal. These highly reactive intermediates have, however, previously escaped experimental observation. A closely entangled combination of experimental and theoretical studies is thus indispensable for detailed analysis of these metallonitrene key intermediates and, ultimately, the exploitation of catalytic nitrogen-atom transfer reactions.
Chemists in the groups of Professor Sven
Schneider, University of Göttingen, and Professor Max Holthausen, 51
Frankfurt, in collaboration with the groups of Professor Joris van Slagern,
University of Stuttgart and Professor Bas de Bruin, University of Amsterdam, have
now been able for the first time to directly observe such a metallonitrene,
measure it spectroscopically and provide a comprehensive quantum-chemical
characterization. To this end, a platinum azide complex was transformed
photochemically into a metallonitrene and examined both magnetometrically and
using photo-crystallography. Together with theoretical modelling, the
researchers have now provided a detailed report on a very reactive
metallonitrene diradical with a single metal-nitrogen bond. The group was furthermore
able to show how the unusual electronic structure of the platinum
metallonitrene allows the targeted insertion of the nitrogen atom into, for
example, C–H bonds of other molecules.
Professor Max Holthausen explains: “The
findings of our work significantly extend the basic understanding of chemical
bonding and reactivity of such metal complexes, providing the basis for a rational
synthesis planning.” Professor Sven Schneider says: “These insertion reactions
allow the use of metallonitrenes for the selective synthesis of organic
nitrogen compounds through catalyst nitrogen atom transfer. This work therefore
contributes to the development of novel ‘green’ syntheses of nitrogen compounds.”
The research was funded by the Deutsche
Forschungsgemeinschaft and the European Research Council.
Publication:
Jian Sun, Josh Abbenseth, Hendrik
Verplancke, Martin Diefenbach, Bas de Bruin, David Hunger, Christian Würtele,
Joris van Slageren, Max C. Holthausen, Sven Schneider: A platinum(II)
metallonitrene with a triplet ground state. Nat. Chem. (2020)
Further
information:
Prof. Dr. Max C. Holthausen
51 Frankfurt am Main
Institute for Inorganic and Analytical Chemistry
Tel.
+49 69 798 29430
max.holthausen@chemie.uni-frankfurt.de
Prof.
Dr. Sven Schneider
Georg-August-Universität
Göttingen
Institute for Inorganic Chemistry
Tel. +49 551 39 22829
sven.schneider@chemie.uni-goettingen.de
Synthetic vesicles are mini-laboratories for customised molecules
Cells of higher organisms use cell organelles to
separate metabolic processes from each other. This is how cell respiration
takes place in the mitochondria, the cell's power plants. They can be compared
to sealed laboratory rooms in the large factory of the cell. A research team at
51 has now succeeded in creating artificial cell organelles and
using them for their own devised biochemical reactions.
FRANKFURT. Biotechnologists
have been attempting to “reprogram" natural cell organelles for other processes
for some time – with mixed results, since the “laboratory equipment" is
specialised on the function of organelles. Dr Joanna Tripp, early career
researcher at the Institute for Molecular Biosciences has now developed a new
method to produce artificial organelles in living yeast cells (ACS Synthetic
Biology: ).
To this end, she used the ramified system
of tubes and bubbles in the endoplasmic reticulum (ER) that surrounds the
nucleus. Cells continually tie off
bubbles, or vesicles, from this membrane system in order to transport substances
to the cell membrane. In plants, these vesicles may also be used for the
storage of proteins in seeds. These storage proteins are equipped with an
“address label" – the Zera sequence – which guides them to the ER and which
ensures that storage proteins are “packaged" there in the vesicle. Joanna Tripp
has now used the “address label" Zera to produce targeted vesicles in yeast
cells and introduce several enzymes of a biochemical metabolic pathway.
This represents a milestone from a
biotechnical perspective. Yeast cells, the “pets" of synthetic biology not only
produce numerous useful natural substances, but can also be genetically changed
to produce industrially interesting molecules on a grand scale, such as
biofuels or anti-malaria medicine.
In addition to the desired products,
however, undesirable by-products or toxic intermediates often occur as well. Furthermore,
the product can be lost due to leaks in the cell, or reactions can be too slow.
Synthetic cell organelles offer remedies, with only the desired enzymes (with
“address labels") encountering each other, so that they work together more
effectively without disrupting the rest of the cell, or being disrupted
themselves.
“We used the Zera sequence to introduce a
three-stage, synthetic metabolic pathway into vesicles," Joanna Tripp explains.
“We have thus created a reaction space containing exactly what we want. We were
able to demonstrate that the metabolic pathway in the vesicles functions in
isolation to the rest of the cell."
The biotechnologist selected an industrially
relevant molecule for this process: muconic acid, which is further processed industrially
to adipic acid. This is an intermediate for nylon and other synthetic
materials. Muconic acid is currently won from raw oil. A future large-scale
production using yeast cells would be significantly more environment-friendly
and sustainable. Although a portion of the intermediate protocatechuic acid is
lost because the vesicle membrane is porous, Joanna Tripp views this as a
solvable problem.
Professor Eckhard Boles, Head of the
Department of Physiology and Genetics of Lower Eukaryotes observes: “This is a
revolutionary new method of synthetic biology. With the novel artificial
organelles, we now have the option of generating various processes in the cell anew,
or to optimise them." The method is not limited to yeast cells, but can be
utilised for eukaryotic cells in general. It can also be applied to other
issues, e.g. for reactions that have previously not been able to take place in
living cells because they may require enzymes that would disrupt the cell
metabolic process.
Publication:
Mara Reifenrath, Mislav Oreb, Eckhard
Boles, Joanna Tripp: Artificial
ER-Derived Vesicles as Synthetic Organelles for in Vivo Compartmentalization of
Biochemical Pathways, in:
ACS Synthetic Biology:
Further
information:
Dr. Joanna Tripp
Institute for Molecular Biosciences
51 Frankfurt
Tel.:
+ 49 69 798 29516
j.tripp@bio.uni-frankfurt.de
Neanderthals introduced solid food in their children’s diet at around 5-6 months of age
Neanderthals behaved not so differently from us in
raising their children, whose pace of growth was similar to Homo sapiens.
Thanks to the combination of geochemical and histological analyses of three
Neanderthal milk teeth, researchers were able to determine their pace of growth
and the weaning onset time. These teeth belonged to three different Neanderthal
children who have lived between 70,000 and 45,000 years ago in a small area of
northeastern Italy.
FRANKFURT/KENT/BOLOGNA/FERRARA. Teeth grow and register information in form of growth lines, akin to tree rings, that can be read through histological techniques. Combining such information with chemical data obtained with a laser-mass spectrometer, in particular strontium concentrations, the scientists were able to show that these Neanderthals introduced solid food in their children's diet at around 5-6 months of age.
Not cultural but physiological
Alessia Nava (University of Kent, UK),
co-first author of the work, says: “The beginning of weaning relates to
physiology rather than to cultural factors. In modern humans, in fact, the
first introduction of solid food occurs at around 6 months of age when the
child needs a more energetic food supply, and it is shared by very different
cultures and societies. Now, we know that also Neanderthals started to wean
their children when modern humans do".
“In particular, compared to other
primates" says Federico Lugli (University of Bologna), co-first author of the
work “it is highly conceivable that the high energy demand of the growing human
brain triggers the early introduction of solid foods in child diet".
Neanderthals are our closest cousins
within the human evolutionary tree. However, their pace of growth and early
life metabolic constraints are still highly debated within the scientific
literature.
Stefano Benazzi (University of Bologna),
co-senior author, says: “This work's results imply similar energy demands
during early infancy and a close pace of growth between Homo sapiens and
Neanderthals. Taken together, these factors possibly suggest that Neanderthal
newborns were of similar weight to modern human neonates, pointing to a likely
similar gestational history and early-life ontogeny, and potentially shorter
inter-birth interval".
Home, sweet home
Other than their early diet and growth,
scientists also collected data on the regional mobility of these Neanderthals
using time-resolved strontium isotope analyses.
“They were less mobile than previously
suggested by other scholars" says Wolfgang Müller (51
Frankfurt), co-senior author “the strontium isotope signature registered in
their teeth indicates in fact that they have spent most of the time close to
their home: this reflects a very modern mental template and a likely thoughtful
use of local resources".
“Despite the general cooling during the
period of interest, Northeastern Italy has almost always been a place rich in
food, ecological variability and caves, ultimately explaining survival of
Neanderthals in this region till about 45,000 years ago" says Marco Peresani
(University of Ferrara), co-senior author and responsible for findings from
archaeological excavations at sites of De Nadale and Fumane.
This research adds a new piece in the
puzzling pictures of Neanderthal, a human species so close to us but still so
enigmatic. Specifically, researchers exclude that the Neanderthal small
population size, derived in earlier genetic analyses, was driven by differences
in weaning age, and that other biocultural factors led to their demise. This
will be further investigated within the framework of the ERC project SUCCESS
('The Earliest Migration of Homo sapiens in Southern Europe - Understanding the
biocultural processes that define our uniqueness'), led by Stefano Benazzi at
University of Bologna.
Picture
downloads:
1.
Fumane Cave near Verona (Wikipedia): This is where several of the
milk teeth of Neanderthal children investigated by Professor Wolfgang Müller at
51 were found.
2.
Neanderthal milk teeth: Presumably a Neanderthal child lost this
tooth 40,000 to 70,000 year ago when his or her permanent teeth came in.
Credit: ERC project SUCCESS, University of Bologna, Italy
3.
Ultra-thin cut: Researchers at 51 cut
paper-thin slices off of a Neanderthal milk tooth. The teeth are subsequently
put back together and reconstructed. Credit/video still: Luca Bondioli and
Alessia Nava, Rome, Italy
Further
information:
Professor Wolfgang
Müller
Institute for Geosciences /
Frankfurt Isotope and Element Research Center (FIERCE)
Tel. +49 (0)69 798 40291,
w.muller@em.uni-frankfurt.de